Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Maximizing Glycemic Benefits of Using Faster Insulin Formulations in Type 1 Diabetes: In Silico Analysis Under Open- and Closed-Loop Conditions

Diabetes Technology & Therapeutics(2023)10.1089/dia.2022.0468Source: DataRank Database

Maximizing Glycemic Benefits of Using Faster Insulin Formulations in Type 1 Diabetes: In Silico Analysis Under Open- and Closed-Loop Conditions is a research paper published in Diabetes Technology & Therapeutics (2023). On theSindex it has a DataRank of 0. It has been cited 12 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access12 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (1 grants)OA: greenTopics (25)IDs (PubMed)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (3)

Patricio Colmegna ORCID,Marc D. Breton ORCID,Jenny L. Diaz C.ORCID

Live enrichment

PubMed:36595379

NIDDK NIH HHS

Grant: R01 DK129553

greenLicense: https://journals.sagepub.com/page/policies/text-and-data-mining-license

repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC10066764/pdf/dia.2022.0468.pdf

publisherhttps://journals.sagepub.com/doi/full-xml/10.1089/dia.2022.0468

publisherhttps://journals.sagepub.com/doi/pdf/10.1089/dia.2022.0468

Fields of Study

AdultHumansBlood GlucoseDiabetes Mellitus, Type 1Hypoglycemic AgentsInsulinInsulin AspartInsulin Infusion SystemsInsulin, Regular, HumanComputer Simulation

MeSH Terms

AdultHumansBlood GlucoseDiabetes Mellitus, Type 1Hypoglycemic AgentsInsulinInsulin AspartInsulin Infusion SystemsInsulin, Regular, HumanComputer Simulation

Keywords

Automated insulin deliveryPharmacokinetic/pharmacodynamic profileTherapy optimizationType 1 diabetesUltrarapid insulin